Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-773
Closed -$205K 377
2025
Q1
$205K Buy
+773
New +$209K ﹤0.01% 360
2024
Q4
Sell
-773
Closed -$245K 385
2024
Q3
$245K Hold
773
﹤0.01% 358
2024
Q2
$289K Hold
773
﹤0.01% 332
2024
Q1
$268K Sell
773
-2
-0.3% -$758 ﹤0.01% 351
2023
Q4
$355K Hold
775
0.01% 317
2023
Q3
$377K Buy
775
+1
+0.1% +$470 0.01% 307
2023
Q2
$346K Buy
774
+1
+0.1% +$503 0.01% 314
2023
Q1
$375K Hold
773
0.01% 306
2022
Q4
$396K Hold
773
0.01% 305
2022
Q3
$375K Hold
773
0.01% 305
2022
Q2
$362K Hold
773
0.01% 307
2022
Q1
$336K Sell
773
-46
-6% -$19.2K 0.01% 325
2021
Q4
$380K Hold
819
0.01% 313
2021
Q3
$319K Hold
819
0.01% 338
2021
Q2
$363K Hold
819
0.01% 325
2021
Q1
$343K Hold
819
0.01% 327
2020
Q4
$336K Hold
819
0.01% 321
2020
Q3
$339K Hold
819
0.01% 290
2020
Q2
$318K Sell
819
-136
-14% -$50.9K 0.01% 287
2020
Q1
$300K Hold
955
0.01% 274
2019
Q4
$350K Buy
+955
New +$303K 0.01% 291

Other funds holding HUM

Welch & Forbes's HUM Position: Q2 2025 in Review

Welch & Forbes sold out of Humana (HUM) in Q2 2025, closing a stake of 773 shares — an estimated $205K sold.

Welch & Forbes first reported a position in HUM in Q4 2019 and held it in 21 quarters. The position peaked at $396K in Q4 2022. 878 funds tracked by Wall St. Rank hold HUM as of Q2 2025.

  • Welch & Forbes reported no remaining Humana position as of Q2 2025 after selling out during the quarter.
  • Welch & Forbes sold 773 Humana shares in Q2 2025, an estimated $205K.
  • Welch & Forbes first reported a position in Humana in Q4 2019 and held it in 21 quarters.
  • Welch & Forbes's Humana position peaked at $396K in Q4 2022.
  • 878 funds tracked by Wall St. Rank held Humana as of Q2 2025.

Based on Welch & Forbes's 13F filing for Q2 2025, filed 5 Aug 2025.